Ignite Creation Date:
2024-05-06 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06229145
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-01-19
Brief Title:
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks Q4W With MTX Compared With Every 2 Weeks Q2W With MTX in Participants With Uncontrolled Refractory Gout
Sponsor:
Organization:
Amgen
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
240
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE4 |
Observational Models:
Time Perspective List:
Who Masked List: